FDA Advises Follow-Up After Calcium Gluconate Recall

Share this article:
Bacterial Infections Linked to Specialty Compounding Products
Bacterial Infections Linked to Specialty Compounding Products

The FDA is advising healthcare professionals to follow-up with patients who received calcium gluconate 10% injections produced by Rx Formulations between November 7 and December 11, 2013. The company recalled the product marketed as sterile on December 13, 2013 due to the identification of gram-positive rod bacteria with microbial contamination in lot #778961. Calcium gluconate is used in the treatment of hypocalcemia.

RELATED: Nutrition Resource Center

Healthcare providers and hospital staff are being warned to investigate their medical supplies immediately and quarantine any affected products. Patients that received a drug produced by Rx Formulations that was marketed as sterile between November 7 and December 11, 2013 should contact their health care provider if they have questions or concerns.

For more information call (818) 344-3344 or visit the FDA Safety Alert page.

Share this article:

Related Resources

close

Next Article in Safety Alerts and Recalls